CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Legato Capital Management LLC 20,526$306,0430.04%
West Tower Group, LLC 5,515$82,2290.04%
Dynamic Technology Lab Private Ltd 27,458$4090.04%
Jump Financial, LLC 63,684$949,5280.04%
ArrowMark Colorado Holdings LLC 179,400$2,674,8540.03%
Quarry LP 9,000$134,1900.03%
BALYASNY ASSET MANAGEMENT L.P. 1,024,139$15,269,9130.03%
Engineers Gate Manager LP 53,982$804,8720.03%
Schonfeld Strategic Advisors LLC 244,620$3,647,2830.03%
Dorsey Wright & Associates 5,956$88,8040.03%
CHARTWELL INVESTMENT PARTNERS, LLC 49,028$7310.03%
TWO SIGMA ADVISERS, LP 668,038$9,960,4470.03%
FRANKLIN RESOURCES INC 3,307,915$49,321,0160.02%
Schonfeld Strategic Advisors LLC 210,000$3,131,1000.02%
Virtu Financial LLC 16,328$2430.02%
Baker Avenue Asset Management, LP 32,800$489,0480.02%
Strategic Blueprint, LLC 16,800$250,4880.02%
VICTORY CAPITAL MANAGEMENT INC 1,037,433$15,468,1260.02%
CARY STREET PARTNERS INVESTMENT ADVISORY LLC 20,000$298,2000.02%
BOOTHBAY FUND MANAGEMENT, LLC 45,300$675,4230.02%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.